Faron Pharmaceuticals - Innovative medical solutions (Part 2)

[poiju]

BEXAR (soft tissue sarcoma) recruitment is apparently starting in just a couple of weeks on July 1, 2026

bexmarilimab + doxorubicin, phase Ib/II

Several centers in Spain.

https://clinicaltrials.eu/trial/study-of-bexmarilimab-plus-doxorubicin-for-safety-and-efficacy-in-adults-with-metastatic-soft-tissue-sarcoma/